Gastric cancer in children infected with Helicobacter pylori

Xia Gong1, Cen Chen1, Jun-Fei Shen2

  • 1Department of Pediatrics, Dazu Hospital of Chongqing Medical University, Chongqing 402360, China.

Insights

Childhood Helicobacter pylori (H. pylori) infection is linked to precancerous gastric conditions. Family history of gastric cancer may increase risk, highlighting the need for early detection and intervention.

Area of Science:

  • Pediatric Gastroenterology
  • Oncology
  • Infectious Diseases

Background:

  • Helicobacter pylori (H. pylori) infection in childhood is a potential risk factor for gastric cancer.
  • Family history of cancer is a known risk factor for gastric cancer.
  • The interplay between childhood H. pylori infection and family history in gastric cancer development requires further investigation.

Purpose of the Study:

  • To define associations between childhood H. pylori infection and gastric cancer risk factors.
  • To specifically evaluate the role of family history of cancer in this association.

Main Methods:

  • Retrospective analysis of upper gastrointestinal endoscopy data from 600 children.
  • Classification of children into H. pylori positive and negative groups based on biopsy and rapid urease tests.
  • Comparison of the incidence of gastric carcinoma, chronic superficial gastritis, glandular atrophy, and intestinal metaplasia between the groups.

Main Results:

  • H. pylori infection was present in 55% (330/600) of the pediatric study population.
  • H. pylori-positive children showed significantly higher rates of chronic superficial gastritis (78.8% vs. 5.9%), gastric atrophy (39.4% vs. 7%), and intestinal metaplasia (0.9% vs. 0%) compared to H. pylori-negative children.
  • A statistically significant association was observed between H. pylori positivity and a family history of gastric cancer (1.2% vs. 0%).

Conclusions:

  • Childhood H. pylori infection is associated with an increased risk of precancerous gastric conditions.
  • Family history of gastric cancer may represent an additional risk factor in children infected with H. pylori.
  • Early detection, intervention, and management of H. pylori in childhood are recommended, particularly for children with a family history of gastric cancer.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
560
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
209
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
728
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
302
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
601
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
500